| View |
|
DRP-12213-01
|
Cefuroxime (as axetil)
|
Quadcef 500
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
NGB Laboratories Pvt. Ltd
|
India
|
-
|
23 September 2022
|
13 July 2027
|
| View |
|
DRP-12392-01
|
Cefalexin (as monohydrate)
|
Cefarap
|
100 mg/mL
|
Powder for Suspension for Oral Drops
|
Antibacterial (First Generation Cephalosporins)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
-
|
23 September 2022
|
21 July 2027
|
| View |
|
DRP-12407-01
|
Cefalexin (as monohydrate)
|
Cefarap
|
125 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporin)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
-
|
23 September 2022
|
21 July 2027
|
| View |
|
DRP-12674
|
Ceftriaxone (as sodium) + Sulbactam (as sodium)
|
Zeftrax S
|
1g/500mg
|
Powder for Injection (I.M/ I.V)
|
-
|
Maan Pharmaceutical Ltd.
|
India
|
-
|
22 September 2022
|
27 July 2026
|
| View |
DRP-12685_PI_01.pdf
|
DRP-12685
|
Iron [equivalent to 250 mg Ferrous Sulfate (Dried)]
|
Anemicon
|
75 mg
|
Capsule
|
Anti-Anemia
|
San Marino Laboratories Corporation
|
Philippines
|
Renewal
|
07 December 2022
|
15 November 2027
|
| View |
|
DRP-12673
|
Ascorbic Acid
|
Mightee-Cee
|
200 mg (equivalent to 225 mg Sodium Ascorbate)
|
|
-
|
Am-Europharma Corporation
|
Philippines
|
-
|
22 September 2022
|
30 January 2025
|
| View |
|
DRP-8055-03
|
Carvedilol
|
None
|
6.25 mg
|
Tablet
|
-
|
Akriti Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 September 2022
|
27 March 2027
|
| View |
|
DRP-10220-02
|
Levocetirizine dihydrochloride
|
L-CER
|
5 mg
|
Tablet
|
-
|
Healer’s Lab (Unit II)
|
India
|
CLIDP Conversion
|
21 September 2022
|
01 October 2026
|
| View |
|
DRP-11276-01
|
Multivitamins + Dextrose
|
Trividex
|
|
Solution for Injection (I.V. Infusion) [see reverse for complete formulation]
|
Parenteral Nutrition
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
CLIDP Conversion
|
21 September 2022
|
22 February 2027
|
| View |
|
DRP-12352-01
|
Fexofenadine hydrochloride
|
Fexophil
|
120 mg
|
Film-Coated Tablet
|
Antihistamine
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
21 September 2022
|
22 July 2027
|
| View |
|
DRP-12669
|
Mycophenolate Mofetil
|
Myfetil
|
500 mg
|
Film-Coated Tablet
|
-
|
Intas Pharmaceuticals, Ltd.
|
India
|
PCPR Conversion
|
21 September 2022
|
22 April 2025
|
| View |
|
DRP-12668
|
Mycophenolate Mofetil
|
Myfetil
|
250 mg
|
Capsule
|
Immunosuppressant
|
Intas Pharmaceuticals, Limited
|
India
|
Renewal
|
13 April 2023
|
27 March 2028
|
| View |
|
DRP-10868-07
|
Ascorbic Acid + Zinc
|
E Cee Plus
|
533.40 mg (equivalent to 600mg Sodium Ascorbate) + 10 mg (equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
Vitamin/ Mineral
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
19 September 2022
|
30 October 2025
|
| View |
|
DRP-12163-01
|
Metoclopramide (as Hydrochloride)
|
Arcimet
|
5 mg/ mL
|
Solution for Injection (IM/IV)
|
Propulsive
|
Farbe Firma
|
India
|
CLIDP Conversion
|
19 September 2022
|
23 June 2027
|
| View |
|
DRP-12353-01
|
Fexofenadine hydrochloride
|
Feuxine
|
180 mg
|
Film-Coated tablet
|
Antihistamine
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 September 2022
|
22 July 2027
|
| View |
|
BRP-100-02
|
Epoetin Alfa
|
Eporife
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
17 September 2022
|
14 December 2026
|
| View |
|
DRP-655-05
|
Ranitidine Hydrochloride
|
Aetin
|
50 mg/2 mL
|
Sterile Solution for Injection (I.M./I.V.)
|
H2 Receptor Antagonist
|
Umedica Laboratories Pvt. Ltd.
|
|
CLIDP Conversion
|
17 September 2022
|
09 October 2025
|
| View |
|
DRP-6556-02
|
Nystatin
|
Nystarex
|
100,000 units/mL
|
Oral Suspension
|
Antifungal
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
17 September 2022
|
07 March 2026
|
| View |
|
DRP-10724-02
|
Ibuprofen
|
Ibupro 400
|
400 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)/Analgesic
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
17 September 2022
|
15 November 2026
|
| View |
|
DRP-11221-01
|
Ciprofloxacin (as Hydrochloride)
|
Ciprollen
|
2 mg/mL (200 mg/100 mL)
|
Solution for Injection (IV Infusion)
|
Antibacterial (Fluoroquinolone)
|
Althea Pharma Pvt. Ltd
|
India
|
CLIDP Conversion
|
17 September 2022
|
15 February 2027
|